New Jersey Mesothelioma Lawyers Report on U.S. Orphan Drug Designation for the Treatment of Mesothelioma in the United States
September 10, 2013– The Philadelphia mesothelioma attorneys at Shein Law are pleased and encouraged by the recent news that orphan drug designation has been granted to Verastem, Inc. by the U.S. Food and Drug Administration for the use of VS-6063 in the treatment of mesothelioma, a rare cancer caused by an exposure to asbestos. This […]